Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 2
1971 2
1972 3
1973 6
1974 3
1975 9
1976 9
1977 10
1978 9
1979 6
1980 10
1981 7
1982 14
1983 14
1984 14
1985 11
1986 18
1987 22
1988 25
1989 36
1990 38
1991 43
1992 29
1993 26
1994 37
1995 35
1996 39
1997 27
1998 29
1999 27
2000 37
2001 25
2002 28
2003 35
2004 19
2005 32
2006 21
2007 43
2008 30
2009 30
2010 26
2011 26
2012 29
2013 37
2014 48
2015 30
2016 44
2017 64
2018 56
2019 48
2020 60
2021 48
2022 57
2023 59
2024 35
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,427 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. Among authors: ayala ar. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW; Diabetic Retinopathy Clinical Research Network. Wells JA, et al. Among authors: ayala ar. Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27. Ophthalmology. 2016. PMID: 26935357 Free PMC article. Clinical Trial.
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Jain N, et al. Among authors: ayala a. JAMA Oncol. 2021 Aug 1;7(8):1213-1219. doi: 10.1001/jamaoncol.2021.1649. JAMA Oncol. 2021. PMID: 34110383 Free PMC article. Clinical Trial.
Apoptosis.
Perl M, Chung CS, Ayala A. Perl M, et al. Among authors: ayala a. Crit Care Med. 2005 Dec;33(12 Suppl):S526-9. doi: 10.1097/01.ccm.0000185499.28006.4c. Crit Care Med. 2005. PMID: 16340441 Review. No abstract available.
Emerging therapeutic targets for sepsis.
Tindal EW, Armstead BE, Monaghan SF, Heffernan DS, Ayala A. Tindal EW, et al. Among authors: ayala a. Expert Opin Ther Targets. 2021 Mar;25(3):175-189. doi: 10.1080/14728222.2021.1897107. Epub 2021 Apr 12. Expert Opin Ther Targets. 2021. PMID: 33641552 Free PMC article. Review.
Demyelinating pseudotumor.
Erana-Rojas IE, Barboza-Quintana A, Ayala AG, Fuller GN. Erana-Rojas IE, et al. Among authors: ayala ag. Ann Diagn Pathol. 2002 Oct;6(5):265-71. doi: 10.1053/adpa.2002.35737. Ann Diagn Pathol. 2002. PMID: 12376918
A review of antimicrobial stewardship training in medical education.
Silverberg SL, Zannella VE, Countryman D, Ayala AP, Lenton E, Friesen F, Law M. Silverberg SL, et al. Among authors: ayala ap. Int J Med Educ. 2017 Oct 12;8:353-374. doi: 10.5116/ijme.59ba.2d47. Int J Med Educ. 2017. PMID: 29035872 Free PMC article. Review.
Chronic stress as a risk factor for Alzheimer's disease.
Machado A, Herrera AJ, de Pablos RM, Espinosa-Oliva AM, Sarmiento M, Ayala A, Venero JL, Santiago M, Villarán RF, Delgado-Cortés MJ, Argüelles S, Cano J. Machado A, et al. Among authors: ayala a. Rev Neurosci. 2014;25(6):785-804. doi: 10.1515/revneuro-2014-0035. Rev Neurosci. 2014. PMID: 25178904 Review.
1,427 results